0001209191-17-044648.txt : 20170710
0001209191-17-044648.hdr.sgml : 20170710
20170710175412
ACCESSION NUMBER: 0001209191-17-044648
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170710
FILED AS OF DATE: 20170710
DATE AS OF CHANGE: 20170710
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Adamas Pharmaceuticals Inc
CENTRAL INDEX KEY: 0001328143
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 421560076
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1900 POWELL ST., SUITE 750
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
BUSINESS PHONE: 510-450-3554
MAIL ADDRESS:
STREET 1: 1900 POWELL ST., SUITE 750
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
FORMER COMPANY:
FORMER CONFORMED NAME: NeuroMolecular Pharmaceuticals Inc
DATE OF NAME CHANGE: 20050524
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MERRIWEATHER ALFRED G
CENTRAL INDEX KEY: 0001211839
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36399
FILM NUMBER: 17958678
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-07-10
0
0001328143
Adamas Pharmaceuticals Inc
ADMS
0001211839
MERRIWEATHER ALFRED G
C/O ADAMAS PHARMACEUTICALS, INC.
1900 POWELL ST., SUITE 750
EMERYVILLE
CA
94608
0
1
0
0
Chief Financial Officer
Common Stock
2017-07-10
4
A
0
18750
0.00
A
18750
D
Stock Option (Right to Buy)
16.98
2017-07-10
4
A
0
112500
0.00
A
2027-07-09
Common Stock
112500
112500
D
Represents the grant of restricted stock units that vest 1/4th on each of September 20, 2018, September 20, 2019, September 20, 2020 and September 20, 2021.
The shares subject to the option shall become vested according to the following schedule: 25% of the shares subject to the option shall vest on June 29, 2018, and the remaining shares will vest in equal monthly installments over the next 36 months.
/s/ Jennifer Rhodes, Attorney-in-fact
2017-07-10